Terumo Europe

Terumo Europe is the European, Middle East and African headquarters of Terumo Corporation, the Japan-based medical technology group. Founded in 1971 and headquartered in Heverlee, Belgium, the company supplies minimally invasive medical products and services across the EMEA healthcare market. It employs 1,411 associates and reports net sales of €839.4 million for fiscal year 2023, operating from 23 locations across the region.

The product portfolio spans several areas of interventional and cardiovascular medicine. Terumo Europe provides Interventional Cardiology devices for the diagnosis and treatment of coronary artery disease, Interventional Oncology devices, Peripheral Intervention devices for peripheral artery disease and other vascular conditions, and Cardiovascular Surgery devices. Its range also includes Injection devices, Infusion Therapy devices and Diabetes Care products. Technical work covers minimally invasive medical technologies, interventional and cardiovascular medical device design, development and manufacturing.

The company describes its approach as conducting business locally while pursuing a unified regional strategy, working closely with healthcare professionals and listening to patient needs. Its stated core values are Respect, Integrity, Care and Quality. Manufacturing excellence is part of its profile: the Heverlee facility in Belgium has been named a “Factory of the Future”.